News About: Pharm. Industry
Financial Gain & Expenditure Report pressures small & medium pharmas
If a pharmaceutical company(or medical device manufacturer) provides financial benefits to healthcare providers, it must write and store a report for them, and if Minister of Health and Welfare(MOHW) asks for this, th...
Celltrion manufactures most pharmaceutical ingredients of KRW 413.9 billion
It was observed the last year’s manufacturing performance of active pharmaceutical ingredients was increased by 18% to KRW 2.4932 trillion compared to the year before.
Moreover, a company which manufactured pharmaceu...
Nagoya Protocol takes effect on 18th, impacting natural drug companies
The Nagoya Protocol on Access and Benefit Sharing(ABS), which regulates constraints to share benefits of using genetic resources, will take effect on the 17th of August.
According to the ABS, a country using genetic ...
Can this happen to me even without signature for rebates?
As a chairman and owner of an influential pharmaceutical company group was arrested for suspicion of rebates on the 7th, other pharmaceutical companies have paid sharp attention to where the case would go; in the mean...
Dong-A Socio, "We'll do our best to explain suspicion during trials"When it comes to the fact its chairman was arrested on the 7th, Dong-A Socio Group announced on the 8th “The court’s arrest decision was not whether it decided guilt and innocen...
|
Ilyang Pharm confirms effect of treating Parkinson’s disease treatment from leukemia treatment ‘Supect’
‘Radotinib(product name: Supect),’ a leukemia treatment developed by Ilyang Pharmaceutical, showed a clinical trial result that it had an effect of treating ‘Parkinson’s disease’ as well.
Ilyang Pharm announced on th...
LG Chem acquires approval of diabetes & dyslipidemia complex for first time in Korea
LG Chem announced ‘Zemiro,’ a complex drug developed for 5 years as a treatment of diabetes and dyslipidemia, was approved to be commercialized in Korea from the Ministry of Food and Drug Safety. It is the first time ...
Who did the best among ‘Big 5’ Pharmas in 1st half of the year?
The last year’s top sales pharmaceutical companies(Yuhan Corporation, Green Cross, Hanmi Pharm, Daewoong Pharmaceutical and Chong Kun Dang) gave official notices about the 1st half business results of this year, but h...
Rapid decrease of Gaviscon sales congests second movers
As sales of ‘Gaviscon,’ an Oxy Reckitt Benckiser’s antipeptic ulcer drug, have rapidly dropped after the humidifier cleaner crisis, products containing alginic acid as a main substance are known to have poor performan...
Sanofi Pasteur appoints Baptiste de Clarens as new CEOSanofi Pasteur, a vaccine department of Sanofi, a global healthcare company, announced appointment of Baptiste de Clarens as a CEO on the last 1st.
De Clarens, the new CEO, rai...
|
